VENKATARAMAN BALAJI
Insider CIK 1114916 · ALIM 10% owner · HZNP · AMHCU Chief Executive Officer, Director, 10% owner · PGNX 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ALIM ALIMERA SCIENCES INC | D To issuer deriv | 2024-09-16 | 2024-09-16 | 800,000 | — | $0 | 0 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | D To issuer deriv | 2024-09-16 | 2024-09-16 | 1,825 | — | $0 | 0 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | D To issuer deriv | 2024-09-16 | 2024-09-16 | 50,000 | — | $0 | 0 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | D To issuer | 2024-09-16 | 2024-09-16 | 9,429,808 | — | $0 | 0 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | D To issuer | 2024-09-16 | 2024-09-16 | 4,178,725 | — | $0 | 0 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | P Buy | 2024-02-08 | 2024-02-09 | 350,000 | $12.95 | $4.53M | 1,188,500 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | A Award deriv | 2023-10-02 | 2023-10-04 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | C Conversion deriv | 2023-08-15 | 2023-08-17 | 8,117 | — | $0 | 0 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | C Conversion deriv | 2023-08-15 | 2023-08-17 | 7,000 | — | $0 | 0 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | C Conversion deriv | 2023-08-15 | 2023-08-17 | 6,000 | — | $0 | 0 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | C Conversion | 2023-08-15 | 2023-08-17 | 4,845,392 | $1.70 | $8.24M | 6,505,046 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | C Conversion | 2023-08-15 | 2023-08-17 | 4,178,725 | $1.70 | $7.10M | 4,178,725 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | C Conversion | 2023-08-15 | 2023-08-17 | 2,924,762 | $2.10 | $6.14M | 9,429,808 | SEC↗ |
| JSPR Amplitude Healthcare Acqui | D To issuer deriv | 2021-09-24 | 2021-09-28 | 200,000 | — | $0 | 0 | SEC↗ |
| JSPR Amplitude Healthcare Acqui | M Exercise deriv | 2021-09-24 | 2021-09-28 | 2,300,000 | — | $0 | 0 | SEC↗ |
| JSPR Amplitude Healthcare Acqui | M Exercise | 2021-09-24 | 2021-09-28 | 2,300,000 | — | $0 | 2,300,000 | SEC↗ |
| AMHCU Amplitude Healthcare Acqui | J Other deriv | 2020-01-03 | 2020-01-07 | 375,000 | — | $0 | 2,500,000 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | P Buy | 2019-09-09 | 2019-09-11 | 72,023 | $4.99 | $359.4K | 8,011,733 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | P Buy | 2019-09-04 | 2019-09-05 | 243,614 | $4.51 | $1.10M | 7,939,710 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | P Buy | 2019-09-03 | 2019-09-05 | 277,424 | $4.39 | $1.22M | 7,696,096 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | P Buy | 2019-08-26 | 2019-08-27 | 73,230 | $4.30 | $314.9K | 7,418,672 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | P Buy | 2019-08-23 | 2019-08-27 | 130,826 | $4.31 | $563.9K | 7,345,442 | SEC↗ |
| HZNP Horizon Pharma plc | S Sale | 2014-11-13 | 2014-11-17 | 6,086,957 | $11.54 | $70.24M | 10,499,360 | SEC↗ |